SBI Life, HDFC AMC To ICICI Pru: Morgan Stanley Raises Target Prices For Key NBFCs Amid RBI Rate Cuts
Morgan Stanley has increased the target prices for several non-banking financial companies, factoring in front-loaded rate cuts by the Reserve Bank of India, equity market movements into their earnings per share estimates and cost of equity assumptions.
Despite these adjustments, Morgan Stanley maintained its ratings and preferred picks, anticipating limited upside and more dispersion in stock returns over the next 12 months.
HDFC AMC
Morgan Stanley maintained an equal-weight rating for HDFC Asset Management Co. and hiked the target price to Rs 4,470 from Rs 3,740.
AB Capital
Morgan Stanley maintained an 'overweight' rating for Aditya Birla Capital Ltd. and increased the target price to Rs 295 from Rs 250.
SBI Life
The brokerage maintained an 'overweight' rating for SBI Life Insurance Co. and raised the target price to Rs 2,115 from Rs 2,050.
ICICI Pru Life
Morgan Stanley maintained an 'equal-weight' rating for ICICI Prudential Life Insurance Co. and increased the target price to Rs 625 from Rs 600.
L&T Finance
The brokerage maintained an 'underweight' rating for L&T Finance Ltd. and hiked the target price to Rs 132 from Rs 115.
Manappuram Finance
Morgan Stanley maintained an 'equal-weight' rating for Manappuram Finance Ltd. and raised the target price to Rs 270 from Rs 220.
HDFC Life
The brokerage maintained an 'overweight' rating for HDFC Life Insurance Co. and increased the target price to Rs 840 from Rs 815.
MCX
Morgan Stanley maintained an 'underweight' rating for Multi Commodity Exchange of India Ltd. and hiked the target price to Rs 5,750 from Rs 3,400.
Home First
The brokerage maintains an 'overweight' rating for Home First Finance Company India Ltd. and has increased the target price to Rs 1,540 from Rs 1,400.
PB Fintech
The brokerage maintained an 'underweight' rating for PB Fintech Ltd. and raised the target price to Rs 1,370 from Rs 1,130. PB Fintech, the parent company of Policybazaar and Paisabazaar, operates as an online platform for insurance and lending products.
Shriram Finance
Morgan Stanley maintained an 'overweight' rating for Shriram Finance Ltd. and hiked the target price to Rs 775 from Rs 750.
Muthoot Finance
The brokerage maintained an 'equal-weight' rating for Muthoot Finance Ltd. and increased the target price to Rs 2,880 from Rs 2,400.
Chola Finance
Morgan Stanley maintained an 'equal-weight' rating for Cholamandalam Investment and Finance Co. and raised the target price to Rs 1,475 from Rs 1,430.
LIC Housing
The brokerage maintained an 'underweight' rating for LIC Housing Finance Ltd. and hiked the target price to Rs 480 from Rs 435.
Morgan Stanley's adjustments reflect the evolving market conditions and the potential impact of RBI's rate cuts on the financial performance of these NBFCs.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
